Unlocking Novel Biology & Rational Design to Develop Potent, Selective & Safer Molecular Glues Cures Against Cancer & Beyond
From Revolution Medicines' landmark FDA approval of RASONQUE™ to major discovery partnerships such as the up to $1.4 billion Novartis-Orionis collaboration, molecular glues continue to generate momentum across both clinical development and early-stage innovation. Combined with rapid advances in artificial intelligence, automation, structural biology, and induced proximity therapeutics, the field is entering a new era of discovery, unlocking previously inaccessible biology and expanding the potential of molecular glues across a growing range of disease areas.
As investment, scientific understanding, and translational success accelerate, the 5th Molecular Glue Drug Development Summit serves as the industry's only dedicated forum bringing together the scientists and drug developers advancing molecular glue therapeutics from early discovery through translational and clinical development.
This meeting serves as a catalyst for innovation bridging basic discovery and translation. Exploring new rational design frameworks and sensitive detection methods will advance our ability to systematically uncover and exploit molecular glue mechanisms
Mikolaj Slabicki, Principal Investigator, Massachusetts General Hospital
This meeting offers an opportunity to hear about a wide variety of strategies being employed to identify molecular glues and to connect with individuals who are bringing a high level of innovative problem solving to these challenges
Patrick Arsenault, Senior Director, Lead Discovery, Triana Biomedicines
As a scientist and entrepreneur, I see tremendous value in participating in the 4th Molecular Glue Drug Development meeting. It brings together leaders across industry and academia to share insights, challenges, and progress in a rapidly evolving field
Anita Bellail, Chief Executive Officer, HB Therapeutics
Explore the 2026 Full Event Guide
- Get the complete agenda, speaker faculty, workshops, and networking opportunities in one place
- Explore the latest advances in molecular glue therapeutics, induced proximity biology, targeted protein degradation, and protein stabilization
- Discover how AI, computational modelling, automation, and structural biology are transforming rational glue discovery
- See which pharma, biotech, academic, and investment leaders are driving the next wave of proximity-based therapeutics
- Share with colleagues to evaluate scientific learnings, partnership opportunities, and commercial potential
Speakers Included:
Attending Companies Included
Explore Related Events
Explore the Agenda
Hear the latest trends in molecular glue development and gain exclusive insights during our packed agenda, interactive roundtables and deep dive workshops.
Partner With Us
Position yourself as a leading solution provider within the molecular glue space to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees developing molecular glues, and make critical connections during our dedicated networking sessions.